Thousands of patients and families have filed lawsuits against Janssen Pharmaceuticals, claiming that the company’s blockbuster blood thinner Xarelto increases the risk for life-threatening bleeding events. More troubling, patients have accused Janssen of concealing the drug’s potential side effects from healthcare providers and the public.
Experienced Xarelto Lawyers Fighting Big Pharma
Over 15,000 Xarelto lawsuits have now been filed. This litigation is progressing quickly, but there is still time for other patients and loved ones to step forward and file Xarelto lawsuits of their own.
Choosing the right lawyer to represent you in a Xarelto lawsuit is a critical decision. The manufacturers of Xarelto are international pharmaceutical giants, backed by billions of dollars in annual revenue. Janssen Pharmaceuticals is a subsidiary of Johnson & Johnson, one of the world’s largest healthcare companies. Both corporate entities have denied all wrongdoing, while retaining armies of experienced defense attorneys to protect their interests.
Despite the stunning explosion of the Xarelto litigation, which now includes more than 15,000 personal injury lawsuits, the drug’s manufacturers intend to defend themselves aggressively. Our attorneys believe that injured patients should be represented with equal experience and tenacity.
An Alliance Of Experienced Litigators
At BloodThinnerHelp.com, we’re proud of our stellar track record when it comes to standing up for the rights of victims of big pharmaceutical giants. However, we know that in fighting for justice against large pharmaceutical companies, we’ll be fighting against a corporation with teams of lawyers and large defense budgets. As a result, we’ve joined forces with other law firms around the country to ensure our clients’ rights are protected aggressively.
In the Xarelto litigation, we have partnered with:
- Monheit Law – a Pennsylvania based personal injury and defective drug and device law firm
- Banville Law – A New York based personal injury and mass tort law firm
Our litigators are known as aggressive trial lawyers, and the settlements and jury verdicts we’ve already won for injured patients are among the largest ever secured against large pharmaceutical companies. In choosing our alliance of experienced Xarelto lawyers, you will have a dedicated team of defective product lawyers in your corner, fighting for your rights.
Meet Our Xarelto Blood Thinner Attorneys
You need experience on your side. You need compassionate attorneys who are committed to keeping you informed.
Michael Monheit is the managing partner of Monheit Law, a Pennsylvania-based law firm that has represented the interests of those injured by the negligence of others. Mr. Monheit has been involved in several large defective drug and product lawsuits throughout his career. Mr. Monheit is an active member of the American Association for Justice.
Mr. Banville is the owner of Banville Law, a New York personal injury law firm. His firm assists those injured in all sort of accidents including slip and fall, construction, and motor vehicle accidents. His practice also is experienced in defective drug and product litigation. His firm is currently handling Xarelto, Eliquis, Zofran, Inovokana, and Power Morcellator lawsuits.
Network Of Xarelto Lawyers Covers All 50 States
While our main legal offices are located in Philadelphia, we have spoken with families interested in bringing Xarelto lawsuits across the United States. Our direct team is licensed to practice law in Pennsylvania, District Of Columbia, Minnesota, and New York, but we’ve developed a network of relationships with local counsel in every state in the country to ensure we can help anyone with questions or an interest in bringing a Xarelto lawsuit.
Our attorneys offer their services on a contingency-fee basis. That means you owe nothing until we secure compensation in your case. We also offer free consultations, so you can learn more about your family’s legal rights at no charge and no obligation.
Just contact us today to find more information.
Approved Without Antidote, Xarelto Under Fire
Xarelto is approved to prevent the formation of blood clots in patients who have been diagnosed with deep vein thrombosis (DVT) and pulmonary embolism (PE), along with people who have non-valvular atrial fibrillation and those undergoing knee and hip replacement procedures.
The drug was specifically designed to compete with warfarin, a medication that has been used to reduce the risk of blood clots for over six decades. Like all blood thinners, warfarin presents a substantial risk of excessive bleeding. In reality, every anticoagulant medication, including Xarelto, creates a similar risk; that’s just how blood thinners work. But there’s a major difference between warfarin and Xarelto, one that patients say makes the new drug unreasonably dangerous.
Xarelto was approved without an antidote. In fact, there’s still no effective reversal agent on the market, which makes controlling internal and external bleeding events extremely difficult. The blood-thinning effects of warfarin, on the other hand, can be reversed quickly through a simple shot of Vitamin K or donor blood plasma.
Federal Xarelto Lawsuits Consolidated In Louisiana
The Xarelto litigation has grown so large that a panel of federal judges decided to consolidate the claims in a single federal court: the US District Court for the Eastern District of Louisiana. The Xarelto MDL includes both the claims of injured patients and wrongful death lawsuits filed by family members who lost loved ones to devastating internal and external bleeds.
In New Orleans, the lawsuits have been progressing through crucial pre-trial proceedings together, as members of a Multi-District Litigation. Significant progress has been made. In fact, a roster of Xarelto lawsuits has already been scheduled for trial. The first case is slated for court on April 14, 2017. While the litigation is moving swiftly, the creation of a Multi-District Litigation, or MDL, has no effect on the rights of patients or families who have yet to come forward.